Crossmark

The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project

Crossref DOI link: https://doi.org/10.1186/s40504-018-0083-0

Published Online: 2018-09-04

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Teare, Harriet J. A. https://orcid.org/0000-0002-3783-7547
de Masi, Federico

Banasik, Karina

Barnett, Anna

Herrgard, Sanna

Jablonka, Bernd

Postma, Jacqueline W. M.

McDonald, Timothy J.

Forgie, Ian

Chmura, Piotr J.

Rydzka, Emil K.

Gupta, Ramneek

Brunak, Soren

Pearson, Ewan

Kaye, Jane
Funding

Funding for this research was provided by:

EU FP7 IMI JU (115317)
License Information

Text and Data Mining valid from 2018-09-04
More Information

Article History

Received: 14 March 2018

Accepted: 23 July 2018

First Online: 4 September 2018

Ethics approval and consent to participate

: Not applicable for this study (for the DIRECT study itself, appropriate ethics approval was received in each of the recruiting countries).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.